找回密碼
 To register

QQ登錄

只需一步,快速開(kāi)始

掃一掃,訪問(wèn)微社區(qū)

打印 上一主題 下一主題

Titlebook: Innovations for Next-Generation Antibody-Drug Conjugates; Marc Damelin Book 2018 Springer International Publishing AG, part of Springer Na

[復(fù)制鏈接]
樓主: 和善
31#
發(fā)表于 2025-3-27 00:06:09 | 只看該作者
32#
發(fā)表于 2025-3-27 04:11:00 | 只看該作者
Combining ADCs with Immuno-Oncology Agents,nogenic cell death (ICD), which leads to potent stimulation of effector T-cell activation as well as their recruitment into tumors. It has been recently demonstrated that some ADC payloads are also able to elicit ICD. Furthermore, several cytotoxic warheads used in ADCs can directly induce dendritic
33#
發(fā)表于 2025-3-27 09:16:23 | 只看該作者
Utility of PK-PD Modeling and Simulation to Improve Decision Making for Antibody-Drug Conjugate Devssful application of this tool can not only enhance the scientific understanding of the processes underlying PK-PD of ADCs but can also provide comprehensive model-derived outcomes that can help accelerate the decision-making process. Within this book chapter, we have discussed an array of different
34#
發(fā)表于 2025-3-27 11:01:43 | 只看該作者
HER2-Targeted ADCs: At the Forefront of ADC Technology Development,different drug linkers, drug to antibody ratios, site-specific antibody drug conjugates, and biparatopic antibody drug conjugates. Anti-HER2 antibody drug conjugates currently in clinical testing are described. Promising early clinical data are emerging from some of the ADCs employing novel technolo
35#
發(fā)表于 2025-3-27 16:54:00 | 只看該作者
36#
發(fā)表于 2025-3-27 21:33:33 | 只看該作者
Next Horizons: ADCs Beyond Oncology, account for designing ADCs for non-oncology indications, including payload and antibody selection. With the evolution of ADC platform and technology, more ADCs for non-oncology indications are yet to be developed.
37#
發(fā)表于 2025-3-28 01:25:40 | 只看該作者
and biomechanics as well as the pathophysiologyleading to various cervical degenerative disorders and the possible neurological sequelae. ?Subsequent chapters outline characteristics of the clinical presentation and the various diagnostic modalities to evaluate these patients. ?Key elements involved
38#
發(fā)表于 2025-3-28 04:38:31 | 只看該作者
39#
發(fā)表于 2025-3-28 09:12:51 | 只看該作者
Frank Comer,Changshou Gao,Steve Coatsspace and promoted a localized IA effect. Subretinal IA dissolved in BSS caused less severe and less consistent PR degeneration. Healon? or BSS alone did not induce PR damage. Thus, a model with PR-lacking area centralis has been created by subretinal injection of IA with a viscous solution. This mo
40#
發(fā)表于 2025-3-28 12:25:37 | 只看該作者
Jack Lin,Jason Sagerts of novel polymers with inherent environmentally favorable properties such as renewability and degradability and a series of interesting monomers found in the metabolisms and cycles of nature are given.978-3-642-07597-1978-3-540-45734-3Series ISSN 0065-3195 Series E-ISSN 1436-5030
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛(ài)論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2026-2-6 20:51
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
北川| 洞头县| 荔波县| 锦屏县| 喀喇沁旗| 昌图县| 嘉定区| 公安县| 彭山县| 宜兰县| 开江县| 宁夏| 昌黎县| 开原市| 蒲城县| 平定县| 铜山县| 克拉玛依市| 阜新市| 黄大仙区| 且末县| 平凉市| 韩城市| 浮山县| 盐池县| 博野县| 西乡县| 东港市| 岐山县| 澳门| 屏东县| 榕江县| 博野县| 乐业县| 门源| 滕州市| 东丽区| 河南省| 磐石市| 广昌县| 贡嘎县|